A data-augmentation method for infectious disease incidence data from close contact groups
暂无分享,去创建一个
[1] A. Nizam,et al. Containing pandemic influenza with antiviral agents. , 2004, American journal of epidemiology.
[2] I. Longini,et al. Household and community transmission parameters from final distributions of infections in households. , 1982, Biometrics.
[3] M. Halloran,et al. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. , 2006, American journal of epidemiology.
[4] M. Elizabeth Halloran,et al. A Frailty Mixture Model for Estimating Vaccine Efficacy , 1996 .
[5] M E Halloran,et al. Efficiency of Estimating Vaccine Efficacy for Susceptibility and Infectiousness: Randomization by Individual Versus Household , 1999, Biometrics.
[6] C. Viboud,et al. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data , 2004, Statistics in medicine.
[7] A. Monto,et al. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. , 2000, The New England journal of medicine.
[8] A. M. Hasofer,et al. Estimation in Epidemics with Incomplete Observations , 1997 .
[9] A. Monto,et al. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. , 2002, The Journal of infectious diseases.
[10] C. Macken,et al. Mitigation strategies for pandemic influenza in the United States. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[11] A. Nizam,et al. Containing Pandemic Influenza at the Source , 2005, Science.
[12] M Elizabeth Halloran,et al. Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups , 2006, Journal of the Royal Statistical Society. Series C, Applied statistics.
[13] D. Balding,et al. Analyses of infectious disease data from household outbreaks by Markov chain Monte Carlo methods , 2000 .
[14] I. Longini,et al. A generalized stochastic model for the analysis of infectious disease final size data. , 1991, Biometrics.
[15] A. Langworthy,et al. An influenza simulation model for immunization studies. , 1976, American journal of epidemiology.
[16] R Brookmeyer,et al. Analysis of infectious disease data from partner studies with unknown source of infection. , 1993, Biometrics.
[17] G. Roberts,et al. Bayesian inference for partially observed stochastic epidemics , 1999 .
[18] E. Lawlor,et al. A likelihood-based method of identifying contaminated lots of blood product. , 1999, International journal of epidemiology.
[19] F. Hayden,et al. Perspectives on antiviral use during pandemic influenza. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[20] M E Halloran,et al. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. , 1997, American journal of epidemiology.
[21] Haitao Chu,et al. Estimating Vaccine Efficacy From Secondary Attack Rates , 2003 .
[22] Xiao-Li Meng,et al. The Art of Data Augmentation , 2001 .
[23] Tom Britton,et al. Estimating Vaccine Effects on Transmission of Infection from Household Outbreak Data , 2003, Biometrics.
[24] R. Paap. What are the advantages of MCMC based inference in latent variable models? , 2002 .
[25] I M Longini,et al. A discrete-time model for the statistical analysis of infectious disease incidence data. , 1992, Biometrics.
[26] D. Rubin,et al. Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .
[27] T. Louis. Finding the Observed Information Matrix When Using the EM Algorithm , 1982 .